Investing Profile

Vikas Goyal

Photo of Vikas Goyal, Principal at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
151 CONNECTIONS
University of Pennsylvania Network
88 CONNECTIONS
McKinsey & Company Network
86 CONNECTIONS
The Wharton School Network
59 CONNECTIONS
cb
SR One Principal
7
CompanyStageDateRound SizeTotal Raised
Pandion Therapeutics
Series AJan 2018$58M
$58M
Spero Therapeutics
Series CMar 2017$51.7M
Series BFeb 2016$30M
Series AJun 2015$30M
$111.7M
Co-investors: Jean-François Formela (Atlas Venture), Michael Gladstone (Atlas Venture)
CalciMedica
Series CDec 2009$12M
Series CJan 2009$4M
Series AJul 2007$1.5M
$17.5M
Associate SR One2011 - Present
Manager, Corporate Strategy & Development Infinity Pharmaceuticals2010 - 2011
Intern SR One2009 - 2010
Co-Chair TiE Social Entrepreneurs2006 - 2008
Senior Associate, Co-Founder Extera Partners2004 - 2008
Associate, PureTech Development PureTech Ventures2004 - 2007
Senior Analyst McKinsey & Company2001 - 2003
The Wharton School MBA Business
University of Pennsylvania MBA Health Care Management
Harvard University BA Neurobiology